ENDRA Life Sciences Inc. Common Stock (NDRA)

Price$4.23

Value ScoreD

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-36.35%

Price vs S&P 500 (4W)-14.54%

VGM Score41.89

Market Capitalization$5.54M

All Metrics

Book Value / Share (Quarterly)$1.44

P/TBV (Annual)21.12x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-6.46

Price vs S&P 500 (YTD)-14.78%

Gross Margin (TTM)51.35%

Net Profit Margin (TTM)-2016.22%

EPS (TTM)$-7.75

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-7.75

EPS (Annual)$-8.93

ROI (Annual)-310.93%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-20124.55%

Cash / Share (Quarterly)$0.29

ROA (Last FY)-182.35%

EBITD / Share (TTM)$-6.79

ROE (5Y Avg)-245.08%

Operating Margin (TTM)-1921.62%

Cash Flow / Share (Annual)$-6.97

P/B Ratio3.10x

P/B Ratio (Quarterly)3.23x

Net Income / Employee (Annual)$-638,900

EV / Revenue (TTM)14.00x

Net Interest Coverage (TTM)-50.00x

ROA (TTM)-242.13%

EPS Incl Extra (Annual)$-8.93

Current Ratio (Annual)1.29x

Quick Ratio (Quarterly)0.43x

3-Month Avg Trading Volume0.08M

52-Week Price Return25.15%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.21

P/S Ratio (Annual)553.75x

Asset Turnover (Annual)0.00x

52-Week High$11.96

Operating Margin (5Y Avg)-18450.33%

EPS Excl Extra (Annual)$-8.93

CapEx CAGR (5Y)106.68%

Tangible BV CAGR (5Y)6.43%

26-Week Price Return-28.43%

Quick Ratio (Annual)1.02x

13-Week Price Return23.32%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.64x

Enterprise Value$5.18M

Asset Turnover (TTM)0.06x

Book Value / Share Growth (5Y)-14.53%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)0.00x

Pretax Margin (Annual)-98000.00%

Cash / Share (Annual)$0.65

3-Month Return Std Dev106.03%

Gross Margin (5Y Avg)62.27%

Net Income / Employee (TTM)$-663,900

ROE (Last FY)-310.93%

EPS Basic Excl Extra (Annual)$-8.93

Receivables Turnover (TTM)2.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-7.75

ROI (TTM)-513.22%

P/S Ratio (TTM)14.97x

Pretax Margin (5Y Avg)-20124.55%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.21

Price vs S&P 500 (52W)0.78%

Year-to-Date Return-6.62%

5-Day Price Return-24.46%

EPS Normalized (Annual)$-8.93

ROA (5Y Avg)-163.84%

Net Profit Margin (Annual)-98000.00%

Month-to-Date Return-23.09%

Cash Flow / Share (TTM)$-2.35

EBITD / Share (Annual)$-7.27

Operating Margin (Annual)-90200.00%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-244.69%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-7.75

P/TBV (Quarterly)21.12x

P/B Ratio (Annual)2.34x

Inventory Turnover (TTM)0.00x

Pretax Margin (TTM)-2016.22%

Book Value / Share (Annual)$1.92

Price vs S&P 500 (13W)15.07%

Beta-0.03x

Revenue / Share (TTM)$0.00

ROE (TTM)-513.22%

52-Week Low$2.96

vGradeD

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-1.80est. -1.25

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.14

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	Price
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	$4.23
MDTMedtronic plc	B	C	C	$81.67
MASIMasimo Corporation	D	D	B	$178.82
LIVNLivaNova PLC Ordinary Shares	C	C	B	$72.36
ITGRInteger Holdings Corporation	B	C	C	$91.98
TMDXTransMedics Group, Inc. Common Stock	C	B	D	$69.43
AXGNAxogen, Inc. Common Stock	F	B	A	$42.80
BLFSBioLife Solutions Inc.	F	B	B	$26.65
CNMDCONMED Corporation	A	C	D	$35.16
INMDInMode Ltd. Ordinary Shares	A	D	C	$13.54
CBLLCeriBell, Inc. Common Stock	D	A	B	$18.25

About

ENDRA Life Sciences develops Thermo Acoustic Enhanced Ultrasound (TAEUS), a point-of-care imaging technology that delivers MRI-quality tissue visualization at ultrasound cost using existing ultrasound systems globally. The company is initially targeting assessment of fatty liver disease (NAFLD/NASH), which affects over 1 billion people worldwide with no practical diagnostic tools currently available. Additional applications include thermal imaging during energy-based surgical procedures.